# Walgreens

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/walgreens
Canonical HTML page: https://getbiobrief.com/entity/walgreens

## Timeline

- **2025**: Data Stabilization — National reports confirm abortion rates remain steady despite ongoing state restrictions.
- **2024-03**: Retail Launch — CVS and Walgreens begin dispensing abortion pills in select states.
- **2023-01**: FDA Rule Change — FDA officially allows retail pharmacies to dispense mifepristone with a prescription.
- **2022-06**: Dobbs Decision — U.S. Supreme Court overturns Roe v. Wade, allowing state-level bans.

## Recent coverage (1 stories)

### U.S. Abortion Rates Remain Resilient Amid State Bans and Telehealth Surge
2026-03-24 07:46:46 · Sentiment: Neutral · Impact: 7/10 · Sources: 10

National data reveals that abortion rates in the United States have remained steady or increased despite a wave of state-level bans following the Dobbs decision. This trend is driven by a significant shift toward medication abortion and the rapid expansion of telehealth services protected by state shield laws.
Full story: https://getbiobrief.com/story/us-abortion-rates-resilient-telehealth-pharma

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.